Related Experiment Video
Updated: Oct 2, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells
B J Sanderson1, K J Johnson, W D Henner
1Division of Hematology and Medical Oncology, Oregon Health Sciences University, Portland 97201.
Abstract:
The alkylating agents in clinical use as antineoplastics are strongly implicated as human carcinogens on the basis of animal studies and human epidemiologic studies. However, there is little quantitative information on the extent to which exposure to these drugs is mutagenic for normal (non-malignant) cells and the extent to which such mutagenicity correlates with cytotoxicity of these agents. Human lymphoblastoid cells (WIL2-NS) were exposed to graded doses of eight antineoplastic alkylating agents. Cell killing and mutation induction at the hypoxanthine -guanine phosphoribosyltransferase (HPRT) locus were measured by cloning in microplates in the presence and absence of 6-thioguanine. Dose-dependent decreases in survival were used to calculate IC50s for each of the drugs tested. The IC50s, for 1 hr exposure, ranged from 4 x 10(-7) M for nitrogen mustard to 5 x 10(-4) M for busulfan. The eight drugs tested each induced detectable increases in the frequency of mutant cells. The mutagenicity of these agents is correlated strongly with cytotoxicity. However, at equitoxic doses (IC50), the frequency of induced mutants ranged from approximately 3 x 10(-6) for 1,3-bis(2-chlorethyl)-1-nitrosourea (BCNU) to 2 x 10(-5) for busulfan and cisplatin. These results quantitate the dose-dependent cytotoxic and mutagenic effects of these bifunctional alkylating agents on human cells. All are cytotoxic and mutagenic, although their mutagenic efficiency varies.
Insights
Eight antineoplastic alkylating agents were tested for mutagenicity and cytotoxicity in human cells. All agents were found to be both cytotoxic and mutagenic, with varying mutagenic efficiency.
Area of Science:
- Pharmacology
- Toxicology
- Genetics
Background:
- Alkylating agents used as antineoplastics are suspected human carcinogens based on animal and human studies.
- Quantitative data on mutagenicity and its correlation with cytotoxicity in normal human cells is limited.
Purpose of the Study:
- To quantify the mutagenic and cytotoxic effects of eight antineoplastic alkylating agents on human lymphoblastoid cells.
- To assess the correlation between mutagenicity and cytotoxicity of these agents.
Main Methods:
- Human lymphoblastoid cells (WIL2-NS) were exposed to varying doses of eight antineoplastic alkylating agents.
- Cell killing (cytotoxicity) and mutation induction at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus were measured.
- IC50 values (concentration for 50% inhibition of survival) were calculated for each drug.
Main Results:
- All eight alkylating agents demonstrated dose-dependent cytotoxicity and induced detectable mutations.
- IC50 values ranged from 4 x 10(-7) M (nitrogen mustard) to 5 x 10(-4) M (busulfan) after 1-hour exposure.
- At equitoxic doses, induced mutant frequencies varied, with 1,3-bis(2-chlorethyl)-1-nitrosourea (BCNU) showing approximately 3 x 10(-6) and busulfan/cisplatin showing 2 x 10(-5).
Conclusions:
- Antineoplastic alkylating agents are both cytotoxic and mutagenic to human cells.
- A strong correlation exists between the cytotoxicity and mutagenicity of these agents.
- The mutagenic efficiency of these bifunctional alkylating agents varies significantly.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Drugs that Destabilize Microtubules
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity
Drug Toxicity: Dose-Dependent Reactions
Spontaneous and Induced Mutations

